NeurologyOnline.net

Neurology Xagena

Search results for "Aubagio"

Disease-modifying therapies ( DMTs ) for multiple sclerosis aim to specifically reduce inflammation in relapsing multiple sclerosis and promote neuroprotection and neurorepair in progressive multiple ...


Results from the TOWER ( Teriflunomide Oral in people With relapsing remitting multiplE scleRosis ) trial that assessed the efficacy and safety of once-daily, oral Teriflunomide ( Aubagio ) in patient ...


Teriflunomide ( Aubagio ) is a once-daily oral immunomodulator approved for the treatment of relapsing-remitting multiple sclerosis. Researchers have assessed the efficacy and safety of Teriflunomi ...


Teriflunomide ( Aubagio ) is an oral disease-modifying therapy approved for treatment of relapsing or relapsing–remitting multiple sclerosis. Researchers aimed to provide further evidence for the sa ...


Multiple sclerosis ( MS ) is a chronic disabling disease of the central nervous system ( CNS ), affecting more than 2 million people worldwide. The disease usually starts in early adulthood, but the ...